Acetylcholine receptor — Drug Target

All drugs that target Acetylcholine receptor — marketed and clinical-stage. Includes 7 drug classes acting on this target.

Drug classes

Nondepolarizing Neuromuscular Blocker · pipecuronium · metocurine · tubocurarine · doxacurium · Botulinum toxin · Antispasmodic

Marketed (8)

• Nimbex · AbbVie · Nondepolarizing Neuromuscular Blocker · Neuroscience
  Nimbex works by blocking the action of acetylcholine at the neuromuscular junction, preventing muscle contraction.
• Nimbex · AbbVie · Nondepolarizing Neuromuscular Blocker · Neuroscience
  Nimbex works by blocking the action of acetylcholine at the neuromuscular junction, preventing muscle contraction.
• Mivacron · AbbVie · Nondepolarizing Neuromuscular Blocker · Neuroscience
• Zemuron · Fresenius Kabi · Nondepolarizing Neuromuscular Blocker · Neuroscience
  Zemuron works by blocking the action of acetylcholine at the neuromuscular junction, preventing muscle contraction.
• PIPECURONIUM · pipecuronium · Neuroscience
• Metocurine · Eli Lilly · metocurine · Neuroscience
• Dextrotubocurarine Chloride · Bristol-Myers Squibb · tubocurarine · Neuroscience
• Bw-A938U · doxacurium · Neuroscience

Phase 2 pipeline (1)

• AbobotulinumtoxinA dose 1 · Galderma R&D · Botulinum toxin · Dermatology
  AbobotulinumtoxinA is a botulinum toxin type A that works by temporarily paralyzing muscles to reduce muscle spasms and improve muscle tone.

Phase 1 pipeline (1)

• A standard antispasmodic · S.LAB (SOLOWAYS) · Antispasmodic · Gastroenterology
  Blocks acetylcholine receptors to relax smooth muscle